论文部分内容阅读
本文通过探究消化内镜并发症产生的具体因素,分析防止并发症出现的治疗方法。筛选消化道内镜诊疗的530例患者详细资料。并根据消化内镜并发症的发病情况分成实验组(并发症组,A组,n=30)以及对照组(无并发症对照组B组,n=500)。对患者进行临床跟踪记录,详细总结两组患者因年龄、性别、体质指数、合并疾病类型等诊疗措施的差异。并根据患者诊疗后出现相关并发症情况分成并发症组(A组,n=30)和无并发症对照组B组两组。经过一段时间的临床治疗观察,实验表明,性别与部分合并疾病类型无明显的统计学差异,而实验组对于年龄超过65岁,并且产生除体质指数、合并心脏病以及高血压病等合并疾病外,所统计的数据均高于对照组的患者,具有统计学差异(P<0.05)。因此,根据该实验结果显示,年龄、体质指数、重度反流性食管炎、心脏病、心内膜炎、高血压病、糖尿病等均为消化内镜诊疗后并发相关并发症的影响因素,建议医师在临床诊疗中重点关注上述高危群体,加强其体征检测及诊疗前后护理防护,以此提高患者就诊安全性。
This article explores the prevention of complications by exploring the specific factors that contribute to the complications of digestive endoscopy. Screening of gastrointestinal endoscopy diagnosis of 530 patients with detailed information. According to the incidence of complications of digestive endoscopy, the patients were divided into experimental group (Complication group, A group, n = 30) and control group (Complication group B, n = 500). Clinical follow-up records of patients, a detailed summary of the two groups due to age, gender, body mass index, the type of combination of treatment and other treatment differences. Patients were divided into two groups according to their complications: group A (n = 30) and group B without complications. After a period of clinical observation, the experiment showed that there was no significant difference between genders and some types of complicated diseases. However, in the experimental group, those older than 65 years old had combined disease such as body mass index, combined heart disease and hypertension , The statistical data were higher than the control group of patients, with statistical differences (P <0.05). Therefore, according to the results of the experiment, age, body mass index, severe reflux esophagitis, heart disease, endocarditis, hypertension and diabetes are the influencing factors of concurrent complications after digestive endoscopy Physicians focus on the above-mentioned high-risk groups in clinical diagnosis and treatment, and strengthen their physical examination before and after the diagnosis and treatment of nursing protection, in order to improve patient safety of treatment.